{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:54:20Z","timestamp":1792756460858,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016499","name":"Rett Syndrome Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016499","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymthe.2023.07.013","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T21:28:29Z","timestamp":1689974909000},"page":"2767-2782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primates"],"prefix":"10.1016","volume":"31","author":[{"given":"Samantha","family":"Powers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibi","family":"Likhite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal K.","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Huffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Dennys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Foust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Pierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Bolon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Kaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-2101","authenticated-orcid":false,"given":"Kathrin C.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.07.013_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1651-2227.1985.tb10993.x","article-title":"Rett\u2019s syndrome: prevalence and impact on progressive severe mental retardation in girls","volume":"74","author":"Hagberg","year":"1985","journal-title":"Acta Paediatr. Scand."},{"key":"10.1016\/j.ymthe.2023.07.013_bib2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s00109-003-0444-9","article-title":"Rett syndrome: the complex nature of a monogenic disease","volume":"81","author":"Renieri","year":"2003","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.ymthe.2023.07.013_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/YCO.0000000000000389","article-title":"Current developments in the genetics of Rett and Rett-like syndrome","volume":"31","author":"Ehrhart","year":"2018","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.ymthe.2023.07.013_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2023.07.013_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/088307389801300507","article-title":"Neonatal encephalopathy in two boys in families with recurrent Rett syndrome","volume":"13","author":"Schanen","year":"1998","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ymthe.2023.07.013_bib6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1212\/WNL.55.8.1188","article-title":"Two affected boys in a Rett syndrome family: Clinical and molecular findings","volume":"55","author":"Villard","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2023.07.013_bib7","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/08830738050200091201","article-title":"Natural history of Rett syndrome","volume":"20","author":"Nomura","year":"2005","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.ymthe.2023.07.013_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1073858402239591","article-title":"The neurobiology of Rett syndrome","volume":"9","author":"Akbarian","year":"2003","journal-title":"Neuroscientist."},{"key":"10.1016\/j.ymthe.2023.07.013_bib9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.45.8.1581","article-title":"Pervasive neuroanatomic abnormalities of the brain in three cases of Rett\u2019s syndrome","volume":"45","author":"Bauman","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2023.07.013_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2023.07.013_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of Neurological Defects in a Mouse Model of Rett Syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2023.07.013_bib12","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic Delivery of MeCP2 Rescues Behavioral and Cellular Deficits in Female Mouse Models of Rett Syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ymthe.2023.07.013_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved Survival and Reduced Phenotypic Severity Following AAV9\/MECP2 Gene Transfer to Neonatal and Juvenile Male Mecp2 Knockout Mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.12.009","article-title":"A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome","volume":"99","author":"Matagne","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ymthe.2023.07.013_bib15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtm.2017.04.006","article-title":"Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery","volume":"5","author":"Sinnett","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.07.013_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nature24058","article-title":"Radically truncated MeCP2 rescues Rett syndrome-like neurological defects","volume":"550","author":"Tillotson","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.07.013_bib17","doi-asserted-by":"crossref","first-page":"165ra163","DOI":"10.1126\/scitranslmed.3003454","article-title":"Long-term follow-up after gene therapy for canavan disease","volume":"4","author":"Leone","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.07.013_bib18","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.07.013_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep22131","article-title":"AAV Gene Therapy for MPS1-associated Corneal Blindness","volume":"6","author":"Vance","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2023.07.013_bib20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins","volume":"19","author":"Nathwani","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib21","doi-asserted-by":"crossref","first-page":"134ra61","DOI":"10.1126\/scitranslmed.3003640","article-title":"Gene Therapy for Aromatic L-Amino Acid Decarboxylase Deficiency","volume":"4","author":"Hwu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.07.013_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52629","article-title":"Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome","volume":"9","author":"Luoni","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2023.07.013_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.21715","article-title":"Autism and other neuropsychiatric symptoms are prevalent in individuals with MECP2 duplication syndrome","volume":"66","author":"Ramocki","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2023.07.013_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/jcu.22065","article-title":"Second-trimester prenasal and prefrontal skin thickening\u2014Association with MECP2 triplication syndrome","volume":"41","author":"Wax","year":"2013","journal-title":"J.\u00a0Clin. Ultrasound"},{"key":"10.1016\/j.ymthe.2023.07.013_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejpn.2011.07.011","article-title":"MECP2 triplication in 3 brothers - A rarely described cause of familial neurological regression in boys","volume":"16","author":"Tang","year":"2012","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymthe.2023.07.013_bib26","unstructured":"Adachi, M., Keefer, E.W., and Jones, F.S. A segment of the Mecp2 promoter is sufficient to drive expression in neurons. 10.1093\/hmg\/ddi402."},{"key":"10.1016\/j.ymthe.2023.07.013_bib27","unstructured":"Liu, J., and Francke, U. Identification of cis-regulatory elements for MECP2 expression. 10.1093\/hmg\/ddl099."},{"key":"10.1016\/j.ymthe.2023.07.013_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/dmcn.15383","article-title":"State-of-the-art therapies for Rett syndrome","volume":"65","author":"Panayotis","year":"2023","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.ymthe.2023.07.013_bib29","first-page":"153","article-title":"Recent Endeavors in MECP2 Gene Transfer for Gene Therapy of Rett Syndrome","volume":"24","author":"Sinnett","year":"2017","journal-title":"Discov. Med."},{"key":"10.1016\/j.ymthe.2023.07.013_bib30","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/brain\/awab182","article-title":"Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice","volume":"144","author":"Sinnett","year":"2021","journal-title":"Brain."},{"key":"10.1016\/j.ymthe.2023.07.013_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006810","article-title":"MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy","volume":"4","author":"Rastegar","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.07.013_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.omtm.2017.04.007","article-title":"Development of a Novel AAV Gene Therapy Cassette with Improved Safety Features and Efficacy in a Mouse Model of Rett Syndrome","volume":"5","author":"Gadalla","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.07.013_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/mt.2014.210","article-title":"Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA : A Dose\u00a0\u2013 response Study in Mice and Nonhuman Primates","volume":"23","author":"Meyer","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ymthe.2020.09.033","article-title":"AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease","volume":"29","author":"Johnson","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib35","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.ymthe.2019.06.015","article-title":"Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease","volume":"27","author":"Cain","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib37","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of MeCP2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.07.013_bib38","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/mt.2013.211","article-title":"Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS","volume":"21","author":"Foust","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib39","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1086\/444549","article-title":"Duplication of the MECP2 Region Is a Frequent Cause of Severe Mental Retardation and Progressive Neurological Symptoms in Males","volume":"77","author":"Van Esch","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2023.07.013_bib40","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/jmedgenet-2017-104956","article-title":"Further delineation of the MECP2 duplication syndrome phenotype in 59 French male patients, with a particular focus on morphological and neurological features","volume":"55","author":"Miguet","year":"2018","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ymthe.2023.07.013_bib42","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02676","article-title":"Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice","volume":"3","author":"Heckman","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2023.07.013_bib44","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/01.gim.0000250502.28516.3c","article-title":"Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males","volume":"8","author":"del Gaudio","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymthe.2023.07.013_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150101","article-title":"MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome","volume":"11","author":"Signorini","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.07.013_bib48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000329580","article-title":"MECP2 duplication syndrome","volume":"2","author":"Van Esch","year":"2012","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.ymthe.2023.07.013_bib50","doi-asserted-by":"crossref","DOI":"10.1177\/2329048X16630673","article-title":"MECP2 Duplications in Symptomatic Females","volume":"3","author":"San Antonio-Arce","year":"2016","journal-title":"Child Neurol. Open"},{"key":"10.1016\/j.ymthe.2023.07.013_bib52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3171\/2017.1.JNS161089","article-title":"A new method of subarachnoid puncture for clinical diagnosis and treatment: Lateral atlanto-occipital space puncture","volume":"129","author":"Gong","year":"2018","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.ymthe.2023.07.013_bib41","article-title":"Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques","author":"Meseck","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2023.07.013_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.omtm.2020.04.001","article-title":"Intra-CSF AAV9 and AAVrh10 Administration in Nonhuman Primates: Promising Routes and Vectors for Which Neurological Diseases?","volume":"17","author":"Bey","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.07.013_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtm.2018.12.001","article-title":"Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates","volume":"13","author":"Ohno","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2023.07.013_bib47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/hum.2014.011","article-title":"Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy","volume":"25","author":"Passini","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3171\/2012.11.JNS111384","article-title":"Comparison of the accuracy of ventricular catheter placement using freehand placement, ultrasonic guidance, and stereotactic neuronavigation","volume":"119","author":"Wilson","year":"2013","journal-title":"J.\u00a0Neurosurg."},{"key":"10.1016\/j.ymthe.2023.07.013_bib51","unstructured":"Keane, J.R., and Angeles, L. Cisternal Puncture Complications Treatment of Coccidioidal Meningitis with Amphotericin B.Calif. Med.,119(3), p.10"},{"key":"10.1016\/j.ymthe.2023.07.013_bib53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1740-8261.2008.00410.x","article-title":"Iatrogenic brainstem injury during cerebellomedullary cistern puncture","volume":"49","author":"Luj\u00e1n Feliu-Pascual","year":"2008","journal-title":"Vet. Radiol. Ultrasound"},{"key":"10.1016\/j.ymthe.2023.07.013_bib54","article-title":"Intra-parenchymal brainstem haemorrhage secondary to iatrogenic needle injury after a parenteral injection in a cat","volume":"2","author":"Brocal","year":"2016","journal-title":"JFMS Open Rep."},{"key":"10.1016\/j.ymthe.2023.07.013_bib55","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/hmg\/ddv496","article-title":"The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome","volume":"25","author":"Brown","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.07.013_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib57","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2020.167","article-title":"Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology","volume":"31","author":"Hordeaux","year":"2020","journal-title":"Human Gene Therapy"},{"key":"10.1016\/j.ymthe.2023.07.013_bib61","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ymthe.2003.08.021","article-title":"Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain","volume":"8","author":"Fu","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib62","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2023.07.013_bib63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/156652310793797685","article-title":"Production, Purification and Characterization of Adeno-Associated Vectors","volume":"10","author":"Ayuso","year":"2010","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.ymthe.2023.07.013_bib64","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng.2714","article-title":"A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome","volume":"45","author":"Buchovecky","year":"2013","journal-title":"Nat. Genet."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623003933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623003933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:09:34Z","timestamp":1761502174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623003933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1525001623003933"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.013","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primates","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}]}}